HER2/neu Overexpression in Bladder Cancer
Author Information
Author(s): Latif Z, Watters A D, Dunn I, Grigor K M, Underwood M A, Bartlett J M S
Primary Institution: University Department of Surgery, Glasgow Royal Infirmary
Hypothesis
The study aims to assess HER2/neu protein overexpression and gene amplification in muscle-invasive transitional cell carcinoma of the bladder.
Conclusion
The study found that HER2/neu abnormalities are present before muscle invasion in bladder cancer.
Supporting Evidence
- 76% of preinvasive tumors showed HER2/neu protein overexpression.
- 92% of postinvasive tumors were polysomic for chromosome 17.
- Gene amplification rates were low, present in 8% of both tumor groups.
Takeaway
This study looked at how a specific protein related to cancer grows in bladder tumors, finding that changes happen before the cancer spreads.
Methodology
The study compared preinvasive and postinvasive tumors from the same patients using immunohistochemistry and fluorescence in situ hybridization.
Potential Biases
Potential bias in tumor selection and assessment methods.
Limitations
The study had a small sample size and relied on retrospective data.
Participant Demographics
Average age of participants was 71.3 years, with 20 males and 5 females.
Statistical Information
P-Value
0.086
Statistical Significance
p=0.086
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website